世界の女性の健康診断市場は、2024年に206億米ドルと評価されており、2025年から2035年の予測期間中に7.30%のCAGR（年平均成長率）で驚異的な成長を遂げると見込まれています。医療分野が精密医療と疾患の早期発見へと移行するにつれ、女性の健康における専門診断の役割はかつてないほど重要になっています。これらの診断は、乳がん、子宮頸がん、生殖健康障害、骨粗鬆症、女性に偏った影響を与える感染症など、疾患の特定とモニタリングに不可欠です。これらの疾患の罹患率の上昇、啓発キャンペーンの強化、スクリーニングプログラムの強化に伴い、医療システムは診断インフラの強化を迫られています。特に分子検査、画像診断装置、AI駆動型診断プラットフォームにおける技術の進歩により、臨床医は疾患をより早期に、より正確に診断できるようになり、治療成果の向上と長期的な医療費の削減に役立っています。
市場の成長勢いは、政府支援によるスクリーニング施策の増加、民間医療機関からの投資の増加、そして予防検査に対する保険適用範囲の拡大によってさらに強化されています。女性の健康に関する世界的なデータは、特に低所得・中所得地域において、乳がんおよび子宮頸がんの症例数が急増していることを浮き彫りにしており、アクセスしやすく手頃な価格の診断ソリューションの緊急の必要性を浮き彫りにしています。さらに、妊娠、不妊治療、性感染症などにおけるポイントオブケア検査の普及は、より分散化され、患者に優しい診断環境を生み出しています。これらの進歩は大きな機会を生み出す一方で、診断機器の高額化、地方における検査インフラの不足、そして高度な医療サービスへのアクセス格差といった課題が市場拡大の妨げとなる可能性があります。しかしながら、研究開発投資の増加とデジタルヘルスソリューションの統合は、今後10年間、業界関係者にとって魅力的な成長見通しをもたらします。
地域別では、北アメリカが現在最大の市場シェアを占めており、これを支えているのは、堅牢な医療インフラ、高度な診断技術、そして早期スクリーニングプログラムの高い導入率です。この地域は、女性の健康に関する研究とイノベーションに対する公的および民間からの強力な資金提供と、専門診断センターの確立されたネットワークの恩恵を受けています。ヨーロッパは、人口全体を対象としたがんスクリーニングの政府による義務化と、医療機関が主導する広範な啓発活動に後押しされ、北アメリカに迫っています。しかし、アジア太平洋地域は、医療費の増加、予防医療への重点化、そして中国やインドなどの新興国における高度な診断ソリューションの導入により、2035年まで最も高い成長を記録すると予想されています。さらに、医療アクセスの改善、急速な都市化、そして好ましい政策枠組みも、この地域における導入率を加速させています。ラテンアメリカと中東・アフリカも、国際協力、民間投資の増加、そして十分な医療サービスを受けていない人々を対象とした診断サービスネットワークの拡大に支えられ、大きな前進を遂げています。
本調査の目的は、近年における様々なセグメントおよび国における市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における業界の定性的および定量的側面の両方を網羅するように設計されており、市場の将来の成長を決定づける推進要因や課題といった重要な側面についても詳細な情報を提供しています。さらに、利害関係者が投資できるマイクロ市場における潜在的な機会、そして主要プレーヤーの競争環境と製品提供の詳細な分析も盛り込んでいます。
目次
Table of Contents
Chapter 1. Global Women’s Health Diagnostics Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study (Historical Data - 2023, 2024; Base Year for Estimation - 2024; Forecast period - 2025-2035)
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Women’s Health Diagnostics Market Forces Analysis
3.1. Market Forces Shaping The Global Women’s Health Diagnostics Market (2024-2035)
3.2. Drivers
3.2.1. Rising prevalence of women-specific conditions (breast/cervical cancer, reproductive disorders) driving screening and diagnostic demand
3.2.2. Technological innovation — molecular diagnostics, imaging advances and AI-enabled platforms improving early detection and throughput
3.3. Restraints
3.3.1. High capital expenditure for advanced diagnostic equipment and expensive consumables limiting adoption in low-resource settings
3.3.2. Inadequate laboratory infrastructure and shortage of skilled personnel in rural/underserved regions impeding market penetration
3.4. Opportunities
3.4.1. Expansion of point-of-care and home-care diagnostics, plus telehealth integration, unlocking new distribution channels and recurring revenue
3.4.2. Government screening initiatives and private-public partnerships in emerging markets supporting large-scale deployment of women’s health diagnostics
Chapter 4. Global Women’s Health Diagnostics Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Women’s Health Diagnostics Market Size & Forecasts by Application 2025-2035
5.1. Market Overview
5.2. Global Women’s Health Diagnostics Market Performance - Potential Analysis (2025)
5.3. Cancer
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Infectious Disease
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
5.5. Osteoporosis
5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.5.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Women’s Health Diagnostics Market Size & Forecasts by End Use 2025-2035
6.1. Market Overview
6.2. Global Women’s Health Diagnostics Market Performance - Potential Analysis (2025)
6.3. Hospitals
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Laboratory
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
6.5. Home Care
6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.5.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Women’s Health Diagnostics Market Size & Forecasts by Region 2025-2035
7.1. Global Women’s Health Diagnostics Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Women’s Health Diagnostics Market
7.3.1. U.S. Women’s Health Diagnostics Market
7.3.1.1. Application breakdown size & forecasts, 2025-2035
7.3.1.2. End Use breakdown size & forecasts, 2025-2035
7.3.2. Canada Women’s Health Diagnostics Market
7.3.2.1. Application breakdown size & forecasts, 2025-2035
7.3.2.2. End Use breakdown size & forecasts, 2025-2035
7.4. Europe Women’s Health Diagnostics Market
7.4.1. UK Women’s Health Diagnostics Market
7.4.1.1. Application breakdown size & forecasts, 2025-2035
7.4.1.2. End Use breakdown size & forecasts, 2025-2035
7.4.2. Germany Women’s Health Diagnostics Market
7.4.2.1. Application breakdown size & forecasts, 2025-2035
7.4.2.2. End Use breakdown size & forecasts, 2025-2035
7.4.3. France Women’s Health Diagnostics Market
7.4.3.1. Application breakdown size & forecasts, 2025-2035
7.4.3.2. End Use breakdown size & forecasts, 2025-2035
7.4.4. Spain Women’s Health Diagnostics Market
7.4.4.1. Application breakdown size & forecasts, 2025-2035
7.4.4.2. End Use breakdown size & forecasts, 2025-2035
7.4.5. Italy Women’s Health Diagnostics Market
7.4.5.1. Application breakdown size & forecasts, 2025-2035
7.4.5.2. End Use breakdown size & forecasts, 2025-2035
7.4.6. Rest of Europe Women’s Health Diagnostics Market
7.4.6.1. Application breakdown size & forecasts, 2025-2035
7.4.6.2. End Use breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Women’s Health Diagnostics Market
7.5.1. China Women’s Health Diagnostics Market
7.5.1.1. Application breakdown size & forecasts, 2025-2035
7.5.1.2. End Use breakdown size & forecasts, 2025-2035
7.5.2. India Women’s Health Diagnostics Market
7.5.2.1. Application breakdown size & forecasts, 2025-2035
7.5.2.2. End Use breakdown size & forecasts, 2025-2035
7.5.3. Japan Women’s Health Diagnostics Market
7.5.3.1. Application breakdown size & forecasts, 2025-2035
7.5.3.2. End Use breakdown size & forecasts, 2025-2035
7.5.4. Australia Women’s Health Diagnostics Market
7.5.4.1. Application breakdown size & forecasts, 2025-2035
7.5.4.2. End Use breakdown size & forecasts, 2025-2035
7.5.5. South Korea Women’s Health Diagnostics Market
7.5.5.1. Application breakdown size & forecasts, 2025-2035
7.5.5.2. End Use breakdown size & forecasts, 2025-2035
7.5.6. Rest of APAC Women’s Health Diagnostics Market
7.5.6.1. Application breakdown size & forecasts, 2025-2035
7.5.6.2. End Use breakdown size & forecasts, 2025-2035
7.6. Latin America Women’s Health Diagnostics Market
7.6.1. Brazil Women’s Health Diagnostics Market
7.6.1.1. Application breakdown size & forecasts, 2025-2035
7.6.1.2. End Use breakdown size & forecasts, 2025-2035
7.6.2. Mexico Women’s Health Diagnostics Market
7.6.2.1. Application breakdown size & forecasts, 2025-2035
7.6.2.2. End Use breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Women’s Health Diagnostics Market
7.7.1. UAE Women’s Health Diagnostics Market
7.7.1.1. Application breakdown size & forecasts, 2025-2035
7.7.1.2. End Use breakdown size & forecasts, 2025-2035
7.7.2. Saudi Arabia (KSA) Women’s Health Diagnostics Market
7.7.2.1. Application breakdown size & forecasts, 2025-2035
7.7.2.2. End Use breakdown size & forecasts, 2025-2035
7.7.3. South Africa Women’s Health Diagnostics Market
7.7.3.1. Application breakdown size & forecasts, 2025-2035
7.7.3.2. End Use breakdown size & forecasts, 2025-2035
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Abbott Laboratories
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Financial Performance (Subject to Data Availability)
8.2.5. Product/Services Port
8.2.6. Recent Development
8.2.7. Market Strategies
8.2.8. SWOT Analysis
8.3. Hologic, Inc.
8.4. Siemens Healthineers AG
8.5. F. Hoffmann-La Roche Ltd.
8.6. Quest Diagnostics Incorporated
8.7. Thermo Fisher Scientific Inc.
8.8. BD (Becton, Dickinson and Company)
8.9. Cardinal Health, Inc.
8.10. Bio-Rad Laboratories, Inc.
8.11. Danaher Corporation
8.12. GE HealthCare Technologies Inc.
8.13. PerkinElmer Inc.
8.14. Fujifilm Holdings Corporation
8.15. Agilent Technologies, Inc.
8.16. GenMark Diagnostics, Inc.
List of Tables
Table 1. Global Women’s Health Diagnostics Market, Report Scope
Table 2. Global Women’s Health Diagnostics Market Estimates & Forecasts By Region 2024-2035
Table 3. Global Women’s Health Diagnostics Market Estimates & Forecasts By Application 2024-2035
Table 4. Global Women’s Health Diagnostics Market Estimates & Forecasts By End Use 2024-2035
Table 5. Global Women’s Health Diagnostics Market Estimates & Forecasts By Segment 2024-2035
Table 6. U.S. Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 7. Canada Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 8. UK Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 9. Germany Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 10. France Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 11. Spain Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 12. Italy Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 13. Rest Of Europe Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 14. China Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 15. India Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 16. Japan Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 17. Australia Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 18. South Korea Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 19. Rest of APAC Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 20. Brazil Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 21. Mexico Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 22. UAE Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 23. Saudi Arabia Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 24. South Africa Women’s Health Diagnostics Market Estimates & Forecasts, 2024-2035
Table 25. Global Women’s Health Diagnostics Market, Company Financial Snapshot (2024)
List of Figures
Fig 1. Global Women’s Health Diagnostics Market, Research Methodology
Fig 2. Global Women’s Health Diagnostics Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global Women’s Health Diagnostics Market, Key Trends 2025
Fig 5. Global Women’s Health Diagnostics Market, Growth Prospects 2024-2035
Fig 6. Global Women’s Health Diagnostics Market, Porter’s Five Forces Model
Fig 7. Global Women’s Health Diagnostics Market, PESTEL Analysis
Fig 8. Global Women’s Health Diagnostics Market, Value Chain Analysis
Fig 9. Women’s Health Diagnostics Market By Application (Cancer, Infectious Disease, Osteoporosis), 2025 & 2035
Fig 10. Women’s Health Diagnostics Market By End Use (Hospitals, Laboratory, Home Care), 2025 & 2035
Fig 11. Women’s Health Diagnostics Market By Segment, 2025 & 2035
Fig 12. North America Women’s Health Diagnostics Market, 2025 & 2035
Fig 13. Europe Women’s Health Diagnostics Market, 2025 & 2035
Fig 14. Asia Pacific Women’s Health Diagnostics Market, 2025 & 2035
Fig 15. Latin America Women’s Health Diagnostics Market, 2025 & 2035
Fig 16. Middle East & Africa Women’s Health Diagnostics Market, 2025 & 2035
Fig 17. Global Women’s Health Diagnostics Market, Competitive Landscape (Company Positioning), 2025
Fig 18. Global Women’s Health Diagnostics Market, Value Chain Stakeholders
Fig 19. Global Women’s Health Diagnostics Market, Company Market Share Analysis (2025)
